Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen–Specific Challenge

BACKGROUND: The live attenuated vaccine Zostavax was developed to prevent varicella zoster virus (VZV) reactivation that causes herpes zoster (shingles) in older humans. However, the impact of vaccination on the cutaneous response to VZV is not known. METHODS: We investigated the response to intrade...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Infect Dis
Autori principali: Patel, Neil P, Vukmanovic-Stejic, Milica, Suarez- Farinas, Mayte, Chambers, Emma S, Sandhu, Daisy, Fuentes-Duculan, Judilyn, Mabbott, Neil A, Rustin, Malcolm H A, Krueger, James, Akbar, Arne N
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Supplement Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6151076/
https://ncbi.nlm.nih.gov/pubmed/30247603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy420
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi